Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya
|
|
- Louisa Whitehead
- 6 years ago
- Views:
Transcription
1 Dr Nick Taylor Visiting Emergency Specialist Teaching Hospital Karapitiya Senior Specialist and Director ED Training Clinical Lecturer, Australian National University Canberra Hospital, Australia
2 Inotropes increase myocardial contractility Vasopressors increase vascular tone
3 BP = CO X SVR CO = SV x HR Pressure does not equal flow No such thing as normal blood pressure perfusion and end organ function are what matters
4 Myocyte stretch Changes in venous return Changes in plasma volume Contractility Sympathetic tone Circulating catecholamines Exogenous inotropes Heart rate Sympathetic and parasympathetic tone Circulating catecholamines Exogenous drugs with chronotropic effects
5
6
7 Endogenous catecholamine with strong α1 agonist activity and modest β1 activity, Strong vasoconstriction and less potent inotropy. Net increase in systolic blood pressure (SBP), diastolic blood pressure, and pulse pressure, Minimal effect on cardiac output Reflex bradycardia from vasoconstriction balances mild chronotropic effects
8 Endogenous catecholamine with high affinity for α1, β1, and β2 receptors Causes vasoconstriction, positive inotropy, and bronchodilation. At high infusion rates the diastolic time is increased and myocytes release local vasodilators leading to increased coronary blood flow Associated with: potent metabolic effects lactic acidosis, hyperglycaemia decreased mesenteric, coronary, and renal conductance reduced renal blood flow
9 Synthetic catecholamine that binds β1 and, to a lesser extent, α1 and β2 receptors. This results in strong inotropic and weaker chronotropic activity. A mild reduction in SVR is a reflex to increased inotropy. Dobutamine s activation of α1 and β2 receptors is of questionable clinical significance. Increases myocardial oxygen consumption (useful in pharmacologic cardiac stress testing) and is potentially harmful to patients at-risk for cardiac ischemia. Significant pharmacologic tolerance can develop after only 72 hours. Safe to administer by peripheral IV but can induce ventricular arrhythmias at any dose.
10 Central neurotransmitter and immediate precursor to nor adrenaline Traditionally, systemic effects are considered dose-dependent. At low infusion rates (0.5 3 mg/kg/min), stimulation of D1 postsynaptic receptors in coronary, renal, mesenteric, and cerebral vascular beds, and D2 presynaptic receptors in renal tissue, result in mild vasodilation and diuresis. The clinical significance of this renal dose of dopamine is unclear. In critically ill patients, low-dose dopamine infusions have been shown not to increase GFR or protect against ARF
11 The increase in splanchnic blood flow and does not alter other measures of mesenteric perfusion. Intermediate doses of dopamine (3 10 mg/kg/min) activate β1 receptors and increase endogenous norad release, increasing cardiac inotropy and SVR. High doses (10 20 mg/kg/min), α1 activity predominates resulting in vasoconstriction and increased SVR. It should be noted that these distinctions are derived generally and in clinical practice the response is patient-specific.
12 Vasopressin, or ADH, is an endogenous hormone stored in the posterior pituitary gland and released in response to increased plasma osmolality, hypotension, pain, nausea, and hypoxia. It is also synthesized by the heart in response to cardiac wall stress, and by the adrenal glands in response to increased catecholamine secretion. It acts on V1 receptors in vascular smooth muscle to induce vaso- constriction, and V2 receptors in the renal collecting tubules to increase collecting duct permeability and renal water reabsorption.
13 Vasopressin increases SVR but reflex increases in systemic vagal tone result in a minimal net effect on cardiac output. Vascular sensitivity to noradrenaline is increased when vasopressin is coadministered, creating a synergistic effect and decreasing the dose (and side effects) of noradrenaline. It may be useful in sepsis because its vasoconstrictive effects are preserved in hypoxic and acidotic conditions.
14 Direct effect on vascular α 1 receptors much greater than β Indirect mechanism of action related to the stimulation of noradrenaline release Useful as bolus dose for temporizing or counteracting anaesthetic drugs Reflex Bradycardia
15 Acts on β 1 receptors and is primarily chronotropic with mild inotropic actions β 2 receptor mediated vasodilation causes a decrease in MAP Proarrhythmic
16 DRUG ACTION DOSE SIDE EFFECTS Noradrenaline α1> β µg/kg/min Tachyarrhythmia, inc myocardial O2 demand Adrenaline α1, β1, β µg/kg/min Tachyarrhythmia, inc myocardial O2 demand, Lactic acidosis Dobutamine β1> β µg/kg/min Tachyarrhythmia, inc myocardial O2 demand, tolerance Dopamine α1, β1, dopa µg/kg/min Tachyarrhythmia, inc myocardial O2 demand Vasopressin α1,v1, V2, V U/min GI hypoperfusion Metaraminol α1>>β mg Reflex bradycardia Isoprenaline β1>> β µg/kg/min Tachyarrhythmia, inc myocardial O2 demand
17
18 55F Cardiogenic shock Presents on Norad 2mcg/kg/min, Adrenaline 1mcg/kg/min, dobutamine 20mcg/kg/min, dopamine 24 mcg/kg/min BP 71/34 Dopa/Dobuta Stopped Adr at 0.5, NA at 0.2: BP 105/45
19 Start at a moderate dose and titrate down when patient is severely hypotensive Remember the lowest dose for your target/end point is what is needed do NOT set and forget In general use no more than 2 agents In general a moderate dose of two is better than a max dose of one and a minimal dose of another Wean the drug with the most side effects first tachycardia will not help diastolic fill time All inotropes/pressors have adverse consequences your job is to optimise the benefit to harm ratio
20 A 46 yo male comes in with 3 days of fever and flank pain. T 105, P 121, BP 75/45 Urine: Nitrate++, WCC ++ He does not improve after 2.5L IV crystalloid What is the diagnosis?
21
22
23 NORADRENALINE (Strong) Rationale: Norad, adrenaline, dopamine and vasopressin can all increase blood pressure in patients with septic shock. The 2012 Surviving Sepsis Guidelines suggest using norepinephrine as the first line agent for these patients.(change from Norad or Dopamine)
24 Two recent large RCTs comparing mortality in patients with shock who were treated with dopamine or norad. One of the RCTs included only patients with septic shock, while the other included patients with all types of shock. The RCT with only septic shock patients demonstrated a mortality benefit in favor of norad. Multiple observational studies demonstrated higher mortality in patients with septic shock who were treated with dopamine. With respect to morbidity, the use of dopamine has been associated with an increased risk of dysrhythmias. There are two recent systematic reviews and a meta-analysis that compare dopamine to norad. Two of the three concluded that norad confers a mortality benefit. All three demonstrated an increased risk of cardiac dysrhythmias when dopamine is used. Vasu TS, Cavallazzi R, Hirani A, et al. Norepinephrine or Dopamine for Septic Shock: Systematic Review of Randomized Clinical Trials. J Intensive Care Med 2012;27: De Backer D, Aldecoa C, Nijmi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: A metaanalysis. Crit Care Med 2012;40(3): Xu B, Oziemski P. Dopamine versus noradrenaline in septic shock. Australasian Med J 2011;4(10):571-4.
25 Initially titrate to an MAP of This target has been shown to provide adequate end organ perfusion and no mortality benefit has been seen with higher MAP targets. Higher MAP (75-85) is associated with fewer patients getting ARF (32% vs 42%)in those with atherosclerosis or HTN at the expense of doubling AF rate and spending longer on vasoactive agents. MAP targets must always be individualized and based on clinically relevant perfusion markers, such as urine output, mental status, skin perfusion, and serum lactate clearance. Initial vasopressor treatment should be concomitant with volume expansion Pierre Asfar et al. High versus Low Blood-Pressure Target in Patients with Septic Shock. N Engl J Med March 18, 2014; DOI: /NEJMoa
26 After starting norad and titrating to 1mcg/kg/min, the patient has a BP of 84/32, UO is poor and he is still poorly perfused peripherally You decide to do a bedside echo A bedside echo shows acute LV hypokinesis
27
28 Previous studies demonstrated that dobutamine improved cardiac index as well as creatinine clearance and gastric microcirculation. More recent studies on the use of dobutamine in septic shock also demonstrated an improvement in cardiovascular parameters, but only limited improvement in microcirculation. Dobutamine is recommended in the 2012 Surviving Sepsis Guidelines for patients who demonstrate low cardiac output despite volume resuscitation.
29 The 2012 Surviving Sepsis Guidelines recommend the addition of adrenaline to noradrenaline when [an] additional agent is needed to maintain adequate blood pressure. Mahmoud et al compared dobutamine to adrenaline for cardiovascular support in patients with septic shock who were already being treated with norad. This study did not show a difference in mortality between the groups. Serum lactate levels and ph were worse in the adrenaline group. Mahmoud K, Ammar A. Norepinephrine supplemented with dobutamine or epinephrine for the cardiovascular support of patients with septic shock. Indian J of Crit Care Med 2012;16(2): Annane D, Vignon P, Renault A, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial. Lancet 2007;370(9588):
30 The patient does not seem to be improving with catecholamine therapy Your consultant asks you to start Vasopressin
31
32 UNCERTAIN. Some patients with septic shock are vasopressin deficient but the clinical importance of this is unknown. When compared to norad as a first line agent for septic shock, vasopressin did not achieve MAP targets and rescue norad was required. Vasopressin has been shown to reduce the dose of catecholamines required to achieve MAP targets in patients with septic shock The VASST study did not demonstrate a survival benefit when a vasopressin infusion was added to patients with septic shock who were already being treated with at least 5 mcg/min of norepinephrine. Subgroup analysis of this study suggested that patients who were on lower doses of norad when vasopressin was initiated might have better survival. 2 subsequent studies suggest a lower mortality when VP is added to low dose Norad
33
34 A 61 yo female presents with LAD STEMI, BP of 70/45 and acute pulmonary oedema Bedside echo reveals septal hypokinesis What is the diagnosis?
35
36 Guidelines suggest aiming for MAP of 65-70, as evidence does not support benefit when higher targets are achieved
37
38 There exists no clear evidence-based recommendation for choice of agents in the setting of cardiogenic shock. The best strategy seems to be noradrenaline if hypotension is severe (SBP <70), or dobutamine if hypotension is moderate (SBP )
39 A large, high-quality, multicenter, randomized trial compared noradrenaline to dopamine as first-line vasopressor therapy for patients presenting in shock. No difference in mortality was found between groups overall Subgroup analysis of cardiogenic shock demonstrated that use of dopamine was associated with a significantly higher 28-day mortality. A Cochrane review suggested that this may have been due to chance There was also a higher incidence of arrhythmia in the dopamine group overall. Other evidence supports the concept that dopamine may be a sub-optimal choice of vasopressor in cardiogenic shock. An analysis of a large, multicenter prospective observational cohort study suggests that dopamine use may be associated with a higher mortality in shock of all etiologies. This further supports the evidence in favour of norepinephrine. De Backer D, Biston P, Devriendt J, et al. Comparison of Dopamine and Norepinephrine in the Treatment of Shock. NEJM 2010;362: Sakr Y, Reinhart K, Vincent JL, et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006;34:
40 Your consultant asks you to change the Norad to Dobutamine Is there any evidence for this?
41 Inotropes are a double edged sword in cardiogenic shock Evidence is not available to definitively answer the question Watch for evidence of further ischaemia Guidelines recommending use are not evidenced based but dobutamine is in common practice No difference bewteen dobutamine + NAdr vs Adr only - except Adr causes lactic acidosis Current recommendations are for dobutamine in decompensated LVF with evidence of poor peripheral perfusion or post AMI shock with BP Use lowest dose to achieve target MAP
42
43 An 18 yo F presents with facial swelling, wheeze and stridor after eating seafood BP is 80/30 First dose of IM Adrenaline is not helping
44
45 Adrenaline is the drug of choice Repeat IM bolus into gluteus Low concentration infusions are easy to make up (0.5mg in 500ml N/Saline) Run at 1ml/kg/hr and increase as needed Methylene blue 1.5mg/kg can be tried for adrenaline resistant anaphylaxis
46 A 51 yo M presents with P 96 and BP 69/35 The cause of shock is unclear
47
48 Evidence from 2 large studies suggests Noradrenaline should be first line due to lower arrhythmogenicity c.f. Dopamine and lower metabolic side effects c.f. Adrenaline De Backer D, Biston P, Devriendt J, et al. Comparison of Dopamine and Norepinephrine in the Treatment of Shock. NEJM 2010;362: Myburgh JA, Higgins A, Jovanovska A, et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008;34(12):
49 A 75 yo man is in a ventricular escape rhythm with a BP of 78/45 Someone is going to get a pacing defibrillator so you can externally pace him What drug should you start in the meantime?
50 Adrenaline is the drug of choice in this circumstance. It has positive chrono/inotropic effects Isoprenaline has now been removed from guidelines as first line because it can worsen hypotension due to vasodilatation
51 No evidence to guide first choice in Neurogenic, obstructive or hypoadrenal shock Hypovolaemic shock should not routinely be given vasoactive drugs
52
53
54 Inotropes and Vasopressors can be safely delivered by Central, Peripheral or Intraosseous routes If peripheral IVs are used, they should be changed to central access after 4-6 hours and placed in large veins only IVs need to be checked first and you need a circulation obs protocol
55 Eighty-five articles with 270 patients met all inclusion criteria. A total of 325 separate local tissue injury and extravasation events were identified, with 318 events resulting from peripheral vasopressor administration and 7 events resulting from central administration. There were 204 local tissue injury events from peripheral administration of vasopressors, with an average duration of infusion of 55.9 hours (±68.1), median time of 24 hours, and range of 0.08 to 528 hours. In most of these events (174/204, 85.3%), the infusion site was located distal to the antecubital or popliteal fossae. CONCLUSIONS: Published data on tissue injury or extravasation from vasopressor administration via peripheral IVs are derived mainly from case reports. Further study is warranted to clarify the safety of vasopressor administration via peripheral IVs A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. Loubani OM1, Green RS2. Crit Care Jun;30(3):653.e9-17. doi: /j.jcrc Epub 2015 Jan 22.
56 Step I If the pt is relying on the agent for their hemodynamics, switch the pressor to another IV or place an immediate IO or central line. Step II Do not pull the cannula yet Step III Suck out as much as you can Step IV Administer subcutaneous phentolamine mesylate (Regitine) using 25 G or smaller needle Comes in 5 mg per 1 ml vials. Place in 9 ml of NS A dose of 0.1 to 0.2 mg/kg (up to a maximum of 10 mg) should then be injected through the catheter and subcutaneously around the site. Administered as soon as the extravasation is detected, even if the area initially looks just a little white or OK. Should see near immediate effects; otherwise consider additional dose. Now pull the catheter. May cause systemic hypotension (but they should be on pressors at another site) Step V Consult Plastics Source:
57 Evidence overall is weak Noradrenaline is first line in most situations Dopamine is proarrhythmogenic and probably leads to higher mortality Adrenaline is equivalent from a mortality perspective but leads to lactic acidosis and more tachycardia Low dose dobutamine is reasonable to add Peripheral access is OK for short term use
58 Emerg Med Clin N Am 32 (2014)
59
60
Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis
Vasoactive Medications Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis Objectives List components of physiology involved in blood pressure Review terminology related
More informationPharmacology of inotropes and vasopressors
Pharmacology of inotropes and vasopressors Curriculum 3.3 Recognises and manages the patient with circulatory failure 4.4 Uses fluids and vasoactive / inotropic drugs to support the circulation PR_BK_41
More informationCase year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50
Case 1 65 year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50 Case 1 65 year old female nursing home resident with
More informationTitrating Critical Care Medications
Titrating Critical Care Medications Chad Johnson, MSN (NED), RN, CNCC(C), CNS-cc Clinical Nurse Specialist: Critical Care and Neurosurgical Services E-mail: johnsoc@tbh.net Copyright 2017 1 Learning Objectives
More informationIntroduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring
Introduction Invasive Hemodynamic Monitoring Audis Bethea, Pharm.D. Assistant Professor Therapeutics IV January 21, 2004 Hemodynamic monitoring is necessary to assess and manage shock Information obtained
More informationSepsis is a complicated infectious process that propagates. Use of Vasopressors in Septic Shock. Clinical review
Use of Vasopressors in Septic Shock Megan A. Rech, PharmD, Megan Prasse, PharmD, and Gourang Patel, PharmD, MSc Abstract Objective: To review the latest findings on the use of vasopressor agents in septic
More informationWhen Fluids are Not Enough: Inopressor Therapy
When Fluids are Not Enough: Inopressor Therapy Problems in Neonatology Neonatal problem: hypoperfusion Severe sepsis Hallmark of septic shock Secondary to neonatal encephalopathy Vasoplegia Syndrome??
More informationVasopressors for shock
Vasopressors for shock Background Reviews and Observational Studies Holler 2015. Nontraumatic Hypotension and Shock in the Emergency Department and Prehospital Setting Prevalence, Etiology and Mortality:
More informationVasoactive Drugs Do I have to choose? Dr. Vandewiele Bert 20 February 2012
Vasoactive Drugs Do I have to choose? Dr. Vandewiele Bert 20 February 2012 What is what? Inotrope A substance that alters the force of muscular contraction (positive/negative) Vasopressor An agent producing
More informationHaemodynamic Support. (getting the blood to go round and round) philippelefevre.com
Haemodynamic Support (getting the blood to go round and round) philippelefevre.com Haemodynamic Support Whats wrong with your patient? What can we do about it? Volume expansion Inotropes, Chronotropes
More informationEvidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
More informationSwans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall
Swans and Pressors Vanderbilt Surgery Summer School Ricky Shinall Shock, Swans, Pressors in 15 minutes 4 Reasons for Shock 4 Swan numbers to know 7 Pressors =15 things to know 4 Reasons for Shock Not enough
More informationSwans and Pressors. Vanderbilt Surgery Summer School Ricky Shinall
Swans and Pressors Vanderbilt Surgery Summer School Ricky Shinall SHOCK Hypotension SHOCK Hypotension SHOCK=Reduction of systemic tissue perfusion, resulting in decreased oxygen delivery to the tissues.
More informationAgenda เอกราช อร ยะช ยพาณ ชย. - Cardiac physiology - Pathophysiology of shock - Pathophysiology of heart failure 9/6/2016
6 September 2016 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Agenda - Cardiac physiology - Pathophysiology of shock - Pathophysiology of heart failure http://fullpulse.weebly.com/conversation
More informationUtilizing Vasopressors:
Utilizing Vasopressors: Critical Care Advances in the Emergency Department José A. Rubero, MD, FACEP, FAAEM Associate Program Director University of Central Florida/HCA GME Consortium Emergency Medicine
More informationThe Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018
The Pharmacology of Hypotension: Vasopressor Choices for HIE patients Keliana O Mara, PharmD August 4, 2018 Objectives Review the pathophysiology of hypotension in neonates Discuss the role of vasopressors
More informationCardiovascular Management of Septic Shock
Cardiovascular Management of Septic Shock R. Phillip Dellinger, MD Professor of Medicine Robert Wood Johnson Medical School/UMDNJ Director, Critical Care Medicine and Med/Surg ICU Cooper University Hospital
More informationการอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล
การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล Distributive shock Severe sepsis and Septic shock Anaphylactic shock Neurogenic
More informationVASOPRESSORS AND INOTROPES CLINICAL PROFESSOR ANDREW BEZZINA FACEM MAY 2017
VASOPRESSORS AND INOTROPES CLINICAL PROFESSOR ANDREW BEZZINA FACEM MAY 2017 CONFLICTS OF INTEREST OVERVIEW Why? When? What? How? WHY? Circulation WHY? - SHOCK!!! Pump (Heart) HYPOVOLAEMIC the pipes have
More informationPHARMACOLOGICAL MANAGEMENT OF CARDIOGENIC SHOCK
PHARMACOLOGICAL MANAGEMENT OF CARDIOGENIC SHOCK Doron Zahger, MD Department of Cardiology, Soroka University Medical Center, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva,
More informationThe Art and Science of Infusion Nursing John M. Allen, PharmD, BCPS. Understanding Vasoactive Medications
The Art and Science of Infusion Nursing John M. Allen, PharmD, BCPS Understanding Vasoactive Medications Focus on Pharmacology and Effective Titration ABSTRACT In the care of the critically ill patient,
More informationUtilizing Vasopressors:
Utilizing Vasopressors: Critical Care Advances in the Emergency Department José A. Rubero, MD, FACEP, FAAEM Associate Program Director University of Central Florida/HCA GME Consortium Emergency Medicine
More informationSurviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.
Surviving Sepsis Campaign Guidelines 2012 & Update for 2015 David E. Tannehill, DO Critical Care Medicine Mercy Hospital St. Louis Be appropriately aggressive the longer one delays aggressive metabolic
More informationUseful diagnostic measures: chest x ray to check pulmonary edema, ECG and ECHO to detect cardiac abnormalities (1).
Cardiogenic shock Etiology The most common cause of cardiogenic shock is LV dysfunction and necrosis as a result of acute myocardial infarction (AMI) (1). Acute valvular insufficiency or stenosis prevents
More informationVasopressors in Septic Shock. Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada
Vasopressors in Septic Shock Keith R. Walley, MD St. Paul s Hospital University of British Columbia Vancouver, Canada Echocardiogram: EF=25% 57 y.o. female, pneumonia, shock Echocardiogram: EF=25% 57 y.o.
More informationHYPOTENSION IS DANGEROUS C. R Y A N K E A Y, M D, F A C E P 1 6 M A R C H
HYPOTENSION IS DANGEROUS C. R Y A N K E A Y, M D, F A C E P 1 6 M A R C H 2 0 1 8 OBJECTIVES Case-based overview of pressors Debunking pressor myths Utilizing push-dose pressors CASE 1 82-year old male,
More informationMedical Treatment for acute Decompensated Heart Failure. Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011
Medical Treatment for acute Decompensated Heart Failure Vlasis Ninios Cardiologist St. Luke s s Hospital Thessaloniki 2011 2010 HFSA guidelines for ADHF 2009 focused update of the 2005 American College
More informationShock and Vasopressors. Nina E. Glass, MD TACS Fellow SICU Didactic Curriculum 9/24/14
Shock and Vasopressors Nina E. Glass, MD TACS Fellow SICU Didactic Curriculum 9/24/14 Review Question Unilaterally diminished breath sounds A. Figure 1 B. Figure 2 C. Both D. Neither Related Specialties
More informationVOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS
Department of Intensive Care Medicine VOLUME RESPONSIVENESS IS DIFFERENT FROM NEED FOR FLUIDS BLOOD PRESSURE TARGETS IN SEPSIS SEPTIC SHOCK : THE CLINICAL SCENARIO HYPOTENSION DESPITE ADEQUATE VOLUME RESUSCITATION
More informationเอกราช อร ยะช ยพาณ ชย
25 September 2017 เอกราช อร ยะช ยพาณ ชย Heart Failure and Transplant Cardiology aekarach.a@chula.ac.th Presentation at 1 Agenda Physiology of the heart Pathophysiology of shock Pathophysiology of heart
More informationMedical Management of Acute Heart Failure
Critical Care Medicine and Trauma Medical Management of Acute Heart Failure Mary O. Gray, MD, FAHA Associate Professor of Medicine University of California, San Francisco Staff Cardiologist and Training
More informationJohn Park, MD Assistant Professor of Medicine
John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development
More informationVASOACTIVE DRUGS AND THEIR USE IN SHOCK. Learning Objectives. Shock 10/5/2016
VASOACTIVE DRUGS AND THEIR USE IN SHOCK October 13, 2016 David Castillo, PharmD, BCPS Emergency Department Lead Clinical Pharmacist Peacehealth Southwest Medical Center DCastillo@peacehealth.org Learning
More informationUpdate in Sepsis. Conflicts of Interest: None. Bill Janssen, M.D.
Update in Sepsis Bill Janssen, M.D. Associate Professor of Medicine National Jewish Health University of Colorado Denver Conflicts of Interest: None A 62 year-old female presents to the ED with fever,
More informationObjectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy
Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of
More informationWhen Fluids are Not Enough: Inopressor Therapy
When Fluids are Not Enough: Inopressor Therapy Problems in Neonatology Neonatal problem: hypoperfusion Severe sepsis Hallmark of septic shock Secondary to neonatal encephalopathy Vasoplegia Syndrome??
More informationFluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,
Fluids in Sepsis Less is more Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth, FRACGP @drsenthi Summary Discussion of the evidence for/against fluid resuscitation in septic shock
More informationMANAGEMENT OF CIRCULATORY FAILURE
MANAGEMENT OF CIRCULATORY FAILURE BACKGROUND AND DEFINITION There is no consensus on the definition of circulatory failure or shock in newborns; it can be defined as global tissue hypoxia secondary to
More informationPediatric Sepsis Treatment:
Disclosures Pediatric Sepsis Treatment: (treat) Early & (reevaluate) Often None June 11, 2018 Leslie Dervan, MD MS Pacific Northwest Sepsis Conference 1 Agenda Sepsis: pathophysiology at-a-glance Pediatric
More informationNorepinephrine (Levophed )
Norepinephrine (Levophed ) Scope C3IFT CCT Generic Name: Norepinephrine Trade Name: Levophed Chemical Class: Therapeutic Class: Actions: Pharmacokinetics: Vasopressor Vasopressor Mechanism of Action: Norepinephrine
More informationINTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017
INTENSIVE CARE MEDICINE CPD EVENING Dr Alastair Morgan Wednesday 13 th September 2017 WHAT IS NEW IN ICU? (RELEVANT TO ANAESTHETISTS) Not much! SURVIVING SEPSIS How many deaths in England were thought
More informationPediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee
Pediatric Septic Shock Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee Case 4 year old male with a history of gastroschesis repaired
More informationWhat works in sepsis. Topics. EGDT: Severe Sepsis/ Shock. Sepsis
What works in sepsis Eric Schmidt, MD Denver Health Medical Center University of Colorado School of Medicine Topics Understanding and implemen@ng early goal directed therapy (EGDT) Ac@vated Protein C should
More information-Cardiogenic: shock state resulting from impairment or failure of myocardium
Shock chapter Shock -Condition in which tissue perfusion is inadequate to deliver oxygen, nutrients to support vital organs, cellular function -Affects all body systems -Classic signs of early shock: Tachycardia,tachypnea,restlessness,anxiety,
More informationMeet the experts: Cardiogenic Shock
Meet the experts: Cardiogenic Shock Inotropes: effects on the heart, the microcirculation and other organs ACCA Masterclass 2017 Alessandro Sionis Director Acute & Intensive Cardiac Care Unit Hospital
More informationIntravenous Inotropic Support an Overview
Intravenous Inotropic Support an Overview Shaul Atar, MD Western Galilee Medical Center, Nahariya Affiliated with the Faculty of Medicine of the Galilee, Safed, Israel INOTROPES in Acute HF (not vasopressors)
More informationAnaesthesia. Cardiovascular. Update in. Inotropes and vasopressors in critical care
Update in Anaesthesia Inotropes and vasopressors in critical care Hannah Dodwell and Bruce McCormick Correspondence Email: hannah.dodwell@doctors.net.uk INTRODUCTION Shock is present in many patients requiring
More information4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures
Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY I have no financial disclosures 1 Objectives Why do we care about sepsis Understanding the core measures by Centers for Medicare
More informationDepartment of Intensive Care Medicine UNDERSTANDING CIRCULATORY FAILURE IN SEPSIS
Department of Intensive Care Medicine UNDERSTANDING CIRCULATORY FAILURE IN SEPSIS UNDERSTANDING CIRCULATORY FAILURE IN SEPSIS a mismatch between tissue perfusion and metabolic demands the heart, the vasculature
More informationSHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function
SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may
More informationPEEP recruitment maneuver
Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF Case 1: 40 yo Male restrained driver high speed MVA P 140, RR 40 labored, BP 100/70, O 2 sat 70 Chest wheeze, crackles
More informationDIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE
DIAGNOSIS AND MANAGEMENT OF ACUTE HEART FAILURE Mefri Yanni, MD Bagian Kardiologi dan Kedokteran Vaskular RS.DR.M.Djamil Padang The 3rd Symcard Padang, Mei 2013 Outline Diagnosis Diagnosis Treatment options
More informationSHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital
SHOCK Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital 1 Definition Shock is an acute, complex state of circulatory dysfunction
More informationNo conflicts of interest
Robert M. Rodriguez, MD FAAEM Clinical Professor of Medicine and Emergency Medicine, UCSF No conflicts of interest Major Points Most ICU patients start in ED Chain of critical care starting in field and
More informationVasoactive drugs. Dr. Zohair Alaseri, MD
Vasoactive drugs Dr. Zohair Alaseri, MD FRCPc, Emergency Medicine FRCPc, Critical Care Medicine Intensivest and Emergency Medicine Consultant Chairman, Department of Emergency Medicine King Saud University
More informationHow to do Primary Angioplasty. - Patients with Cardiogenic Shock
How to do Primary Angioplasty - Patients with Cardiogenic Shock Advanced Cardiovascular Intervention 2011 Dan Blackman Leeds General Infirmary MY CONFLICTS OF INTEREST ARE: Research Grants Medicines Company
More informationPercutaneous Mechanical Circulatory Support for Cardiogenic Shock. 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI
Percutaneous Mechanical Circulatory Support for Cardiogenic Shock 24 th Annual San Diego Heart Failure Symposium Ryan R Reeves, MD FSCAI The Need for Circulatory Support Basic Pathophysiologic Problems:
More informationSepsis and Hemodynamic Support in September 15, 2017 Carleen Risaliti
Sepsis and Hemodynamic Support in 2017 September 15, 2017 Carleen Risaliti Objectives Review fluid resuscitation guidelines in septic shock Discuss volume assessment v. fluid responsiveness Evaluate pros
More informationDilemmas in Septic Shock
Dilemmas in Septic Shock William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center A 62 year-old female presents to the ED with fever,
More informationCardiogenic shock: Current management
Cardiogenic shock: Current management Janine Pöss Universitätsklinikum des Saarlandes Klinik für Innere Medizin III Kardiologie, Angiologie und internistische Intensivmedizin Homburg/Saar I have nothing
More informationEFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz
EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK Alexandria Rydz BACKGROUND- SEPSIS Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated
More informationShock Quiz! By Clare Di Bona
Shock Quiz! By Clare Di Bona Test Question What is Mr Burns full legal name? Answer Charles Montgomery Plantagenet Schicklgruber Burns. (Season 22, episode 11) Question 1. What is the definition of shock?
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationTaking the shock factor out of shock
Taking the shock factor out of shock Julie Antonellis, BS, LVT, VTS (ECC) Northern Virginia Regional Director for the VALVT Technician Supervisor VCA Animal Emergency Critical Care Business owner Antonellis
More informationSHOCK. Pathophysiology
SHOCK Dr. Ahmed Saleem FICMS TUCOM / 3rd Year / 2015 Shock is the most common and therefore the most important cause of death of surgical patients. Death may occur rapidly due to a profound state of shock,
More informationHOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT.
HOW LOW CAN YOU GO? HYPOTENSION AND THE ANESTHETIZED PATIENT. Donna M. Sisak, CVT, LVT, VTS (Anesthesia/Analgesia) Seattle Veterinary Specialists Kirkland, WA dsisak@svsvet.com THE ANESTHETIZED PATIENT
More informationNeonatal Shock. Imbalance between tissue oxygen delivery and oxygen consumption
Neonatal Shock Moira Crowley, MD Assistant Professor, Pediatrics Co-director, Neonatal ECMO Program Rainbow Babies and Children s Hospital Case Western Resverve University School of Medicine 1 Objectives
More informationIntravenous Infusions
Intravenous Infusions 1) An IV insulin infusion can be used for patients: a) with out of control diabetes b) with DKA (Diabetic Ketoacidosis) c) after a heart attack 2) Hyperglycemia is an adaptive response
More informationVasopressors in septic shock
Vasopressors in septic shock Prof. Jean-Louis TEBOUL Medical ICU Bicetre hospital University Paris-South France Questions 1- Why do we use vasopressors in septic shock? 2- Which first-line agent? 3- When
More informationMedical Management of Acutely Decompensated Heart Failure. William T. Abraham, MD Director, Division of Cardiovascular Medicine
Medical Management of Acutely Decompensated Heart Failure William T. Abraham, MD Director, Division of Cardiovascular Medicine Orlando, Florida October 7-9, 2011 Goals of Acute Heart Failure Therapy Alleviate
More informationFluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
More informationPhysiologic Based Management of Circulatory Shock Kuwait 2018
Physiologic Based Management of Circulatory Shock Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Echocardiography, Point of Care and Hemodynamics Program Staff Neonatologist
More informationDESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS
DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS R. Phillip Dellinger MD, MSc, MCCM Professor and Chair of Medicine Cooper Medical School of Rowan University Chief of Medicine Cooper University Hospital
More information9/13/2015. Laboratory. HPI and PE
Critical Care HPI and PE 74 yo male confused SBP 90/20 MAP50, P 122, RR 34 Ox1 w/o nuchal rigidity S1S2 wo m RLL reduced breath sounds Skin warm dry Laboratory» WBC 15,600 Hgb 8.4 HCt 23%, Plts 95000,
More informationAcute Liver Failure: Supporting Other Organs
Acute Liver Failure: Supporting Other Organs Michael A. Gropper, MD, PhD Professor of Anesthesia and Physiology Director, Critical Care Medicine University of California San Francisco Acute Liver Failure
More informationObjectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated
Update on Surviving Sepsis 2008 Objectives Epidemiology of Sepsis Definition of Sepsis and Septic Shock Review Guidelines for Resuscitation Dx: Lactate, t cultures, SVO2 Tx: EGDT, timing/choice of abx,
More informationSHOCK in Paediatric Trauma
SHOCK in Paediatric Trauma Speaker: Tang Sze Kit, (Fellow, Hong Kong College of Paediatric Nursing, MSc, MN, BN) Date: 26/4/2016 Time: 18:30-19:30 Venue: Paediatrics & Adolescent Ambulatory Centre, G/F,
More information12RC3 Martin. Haemodynamic Management of Septic Shock. Claude Martin, Introduction. Objectives in the initial resuscitation of septic shock - 1 -
12C3 Martin Haemodynamic Management of Septic Shock Claude Martin, Département d nesthésie et de éanimation et Centre de Traumatologie, Hôpital Nord, ssistance Publique-Hôpitaux de Marseille, 13915 Marseille
More informationMeans failure of heart to pump enough blood to satisfy the need of the body.
Means failure of heart to pump enough blood to satisfy the need of the body. Due to an impaired ability of the heart to adequately to fill or eject blood. HEART FAILURE Heart failure (HF) means decreased
More informationDisclosures. Objectives 10/11/17. Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock. I have no disclosures to report
Short Term Mechanical Circulatory Support for Advanced Cardiogenic Shock Christopher K. Gordon MSN, ACNP-BC Disclosures I have no disclosures to report 1. Pathophysiology 2. Epidemiology 3. Assessment
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More informationWHAT DO YOU SEE WHEN YOU STIMULATE BETA
CARDIAC DRUG REVIEW WHAT DO YOU SEE WHEN YOU STIMULATE BETA VASODILATE BRONCHODILATE +CHRONOTROPE +INOTROPE EPI S OTHER NAME? ADRENALIN WHAT DOES EPI DO THAT NOREPI AND DOPAMINE DO NOT DO? BETA 2 BRONCHODILATOR
More informationCardiovascular Active Medications
Co-assistenten 2015-2016 L. Al tmimi, MD, PhD Student Department of Anesthesia University hospitals Leuven Introduction Many drugs are used to manage hemodynamic before, during and after any operation
More informationa)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline, isoprenaline, dopamine, dobutamine
1 Adrenergic or sympathetic agonist: Are classified according to: I)- according to the chemical structure a)-catecholamines // these are compounds which have the catechol nucleus as adrenaline, noradrenaline,
More informationAgenda. 1. Anatomy and physiology of the heart. 2. Pathophysiology of shock. 3. Pathophysiology of heart failure. 04-Sep-18
เอกราช อร ยะช ยพาณ ชย Aekarach Ariyachaipanich, MD, FACC aekarach.a@chula.ac.th CVS 2 3000378 4.09.2018 Agenda 1. Anatomy and physiology of the heart 2. Pathophysiology of shock 3. Pathophysiology of heart
More informationNothing to Disclose. Severe Pulmonary Hypertension
Severe Ronald Pearl, MD, PhD Professor and Chair Department of Anesthesiology Stanford University Rpearl@stanford.edu Nothing to Disclose 65 year old female Elective knee surgery NYHA Class 3 Aortic stenosis
More informationUpdate in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
More informationPost Cardiac Arrest Care 2015 American Heart Association Guideline Update for CPR and Emergency Cardiovascular Care
Post Cardiac Arrest Care 2015 American Heart Association Guideline Update for CPR and Emergency Cardiovascular Care รศ.ดร.พญ.ต นหยง พ พานเมฆาภรณ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร มหาว ทยาล ยเช ยงใหม System
More informationHypotension in the Neonate
Neonatal Nursing Education Brief: Hypotension in the Neonate http://www.seattlechildrens.org/healthcare-professionals/education/continuing-medicalnursing-education/neonatal-nursing-education-briefs/ Neonatal
More informationBIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1
BIPN100 F15 Human Physiol I (Kristan) Lecture 14 Cardiovascular control mechanisms p. 1 Terms you should understand: hemorrhage, intrinsic and extrinsic mechanisms, anoxia, myocardial contractility, residual
More informationSepsis is an important issue. Clinician s decision-making capability. Guideline recommendations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%
More informationSepsis and septic shock Practical hemodynamic consequences. Intensive Care Training Program Radboud University Medical Centre Nijmegen
Sepsis and septic shock Practical hemodynamic consequences Intensive Care Training Program Radboud University Medical Centre Nijmegen Septic cardiomyopathy Present in > 50% and often masked by low vascular
More informationIntraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend )
Intraaortic Balloon Counterpulsation- Supportive Data for a Role in Cardiogenic Shock ( Be Still My Friend ) Stephen G. Ellis, MD Section Head, Interventional Cardiology Professor of Medicine Cleveland
More informationCase Scenario 3: Shock and Sepsis
Name: Molly Boyle 1. Define the term shock (Lewis textbook): Shock is a syndrome characterized by decreased perfusion and impaired metabolism. Shock can have a number of causes that result in damage to
More informationActualités de la prise en charge hémodynamique initiale Daniel De Backer
Actualités de la prise en charge hémodynamique initiale Daniel De Backer Head Dept Intensive Care, CHIREC hospitals, Belgium Professor of Intensive Care, Université Libre de Bruxelles Past- President European
More informationFluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
More informationSeptic Acute Kidney Injury (AKI) Rinaldo Bellomo Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) Melbourne Australia
Septic Acute Kidney Injury (AKI) Rinaldo Bellomo Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) Melbourne Australia Things we really, honestly know about septic AKI AKI is common
More informationRounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center
Rounds in the ICU Eran Segal, MD Director General ICU Sheba Medical Center Real Clinical cases (including our mistakes) Emphasis on hemodynamic monitoring Usually no single correct answer We will conduct
More informationACLS Review. Pulse Oximetry to be between 94 99% to avoid hyperoxia (high oxygen tension can lead to tissue death
ACLS Review BLS CPR BLS CPR changed in 2010. The primary change is from the ABC format to CAB. After establishing unresponsiveness and calling for a code, check for a pulse less than 10 seconds then begin
More informationTowards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:
Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood
More information